A new study finds that the U.S. pays up to 4.1 times more for brandnamed prescription drugs than in other countries and that if Medicare Part D had used the same pricing as others the U.S. could have saved nearly $73 billion last year. httpsbuff.ly

A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/

A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/2JABTX5 

More From BioPortfolio on "A new study finds that the U.S. pays up to 4.1 times more for brand-named prescription drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/"